000 | 01544 a2200457 4500 | ||
---|---|---|---|
005 | 20250513170504.0 | ||
264 | 0 | _c19990524 | |
008 | 199905s 0 0 eng d | ||
022 | _a1368-4736 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKatz, A | |
245 | 0 | 0 |
_aIncreased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. _h[electronic resource] |
260 |
_bCytokines, cellular & molecular therapy _cDec 1998 |
||
300 |
_a221-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAldehydes _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 |
_aCarbon Tetrachloride _xtoxicity |
650 | 0 | 4 | _aChimera |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aInterleukin-6 _xdeficiency |
650 | 0 | 4 | _aLipid Peroxidation |
650 | 0 | 4 |
_aLiver _xanatomy & histology |
650 | 0 | 4 |
_aMalondialdehyde _xpharmacology |
650 | 0 | 4 |
_aMelanoma, Experimental _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aReceptors, Interleukin-6 _xchemistry |
650 | 0 | 4 | _aSurvival |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aChebath, J | |
700 | 1 | _aFriedman, J | |
700 | 1 | _aRevel, M | |
773 | 0 |
_tCytokines, cellular & molecular therapy _gvol. 4 _gno. 4 _gp. 221-7 |
|
999 |
_c10028121 _d10028121 |